Understanding the causes of non-immune hydrops fetalis through genetic analysis
Uncovering the etiologies of non-immune hydrops fetalis through comprehensive genomic analyses and phenotyping
This study is looking into the genetic causes of non-immune hydrops fetalis (NIHF), a condition where extra fluid builds up in a baby during pregnancy, to help doctors provide better care for both moms and their babies.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-11020996 on NIH RePORTER |
What this research studies
This research investigates non-immune hydrops fetalis (NIHF), a condition diagnosed during pregnancy when abnormal fluid accumulates in the fetus. By utilizing advanced genomic analyses and phenotyping, the study aims to identify the genetic causes of NIHF, which can significantly affect prenatal and postnatal care. The research will analyze genetic data from affected pregnancies to provide targeted management strategies, improving outcomes for both mothers and infants. The goal is to enhance the understanding of NIHF and implement timely interventions based on identified etiologies.
Who could benefit from this research
Good fit: Ideal candidates for this research include pregnant individuals whose fetuses have been diagnosed with non-immune hydrops fetalis and for whom the cause remains unknown.
Not a fit: Patients whose non-immune hydrops fetalis has a known cause or those not diagnosed with this condition may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved prenatal care and better health outcomes for infants diagnosed with non-immune hydrops fetalis.
How similar studies have performed: Previous research has shown success in identifying genetic causes of similar conditions, indicating that this approach has the potential for meaningful advancements.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Sparks, Teresa N — University of California, San Francisco
- Study coordinator: Sparks, Teresa N
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.